Abbott Laboratories
SIX:ABT
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
Abbott Laboratories
SIX:ABT
|
US |
|
Galatasaray Sportif Sinai ve Ticari Yatirimlar AS
IST:GSRAY.E
|
TR |
|
Bucher Industries AG
SIX:BUCN
|
CH |
|
First Majestic Silver Corp
TSX:FR
|
CA |
|
Aguia Resources Ltd
ASX:AGR
|
AU |
|
Leonardo SpA
MIL:LDO
|
IT |
|
J
|
JG Boswell Co
OTC:BWEL
|
US |
|
H
|
Heineken Malaysia Bhd
KLSE:HEIM
|
MY |
|
C
|
Cakra Buana Resources Energi PT Tbk
IDX:CBRE
|
ID |
|
W
|
Wartsila Oyj Abp
DUS:MTA
|
FI |
|
Forestar Group Inc
NYSE:FOR
|
US |
|
Jardine Matheson Holdings Ltd
OTC:JMHLY
|
HK |
|
A
|
Auto Partner SA
WSE:APR
|
PL |
|
N
|
Navigator Company SA
ELI:NVG
|
PT |
|
Cadre Holdings Inc
NYSE:CDRE
|
US |
|
Paramount Global
NASDAQ:PARA
|
US |
|
M
|
Melia Hotels International SA
SWB:MEL
|
ES |
|
Sonos Inc
NASDAQ:SONO
|
US |
|
Chicago Atlantic Real Estate Finance Inc
NASDAQ:REFI
|
US |
|
D
|
Dechra Pharmaceuticals PLC
F:1PK
|
UK |
|
Power Grid Corporation of India Ltd
BSE:532898
|
IN |
|
B
|
Bangkok Expressway and Metro PCL
SET:BEM
|
TH |
|
Nexpoint Real Estate Finance Inc
NYSE:NREF
|
US |
|
Goodtech ASA
OSE:GOD
|
NO |
Wall St Price Targets
ABT Price Targets Summary
Abbott Laboratories
According to Wall Street analysts, the average 1-year price target for ABT is 129.809 CHF with a low forecast of 98.8278 CHF and a high forecast of 159.6965 CHF.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is ABT's stock price target?
Price Target
129.809
CHF
According to Wall Street analysts, the average 1-year price target for ABT is 129.809 CHF with a low forecast of 98.8278 CHF and a high forecast of 159.6965 CHF.
What is the Revenue forecast for Abbott Laboratories?
Projected CAGR
9%
Over the last 13 years, the compound annual growth rate for Revenue has been 7%. The projected CAGR for the next 5 years is 9%.
What is the Operating Income forecast for Abbott Laboratories?
Projected CAGR
16%
Over the last 13 years, the compound annual growth rate for Operating Income has been 15%. The projected CAGR for the next 5 years is 16%.
What is the Net Income forecast for Abbott Laboratories?
Projected CAGR
17%
Over the last 13 years, the compound annual growth rate for Net Income has been 1%. The projected CAGR for the next 5 years is 17%.
